Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Roivant Sciences Ltd.SHS(ROIV) | 8,020,928 | 7,710,928 | -310,000 | $283.86M | $281.99M | 45.00% | -$1.87M |
| Revolution Medicines, Inc.(RVMD) | 276,000 | 196,000 | -80,000 | $51.69M | $40.23M | 6.42% | -$11.46M |
| United Therapeutics Corporation(UTHR) | 37,120 | 62,677 | +25,557 | $20.11M | $33.96M | 5.42% | +$13.85M |
| argenx SEADR(ARGX) | 23,000 | 28,000 | +5,000 | $21.34M | $26.85M | 4.28% | +$5.51M |
| Pharvaris N V COM | 671,209 | 808,644 | +137,435 | $23.21M | $25.65M | 4.09% | +$2.44M |
| ABIVAX Société AnonymeADS(ABVX) | 206,500 | 243,000 | +36,500 | $27.52M | $24.06M | 3.84% | -$3.46M |
| Belite Bio, IncADS(BLTE) | 110,000 | 131,700 | +21,700 | $16.94M | $22.37M | 3.57% | +$5.43M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 260,500 | 234,000 | -26,500 | $30.50M | $20.00M | 3.19% | -$10.49M |
| Zai Lab LimitedADR(ZLAB) | 0 | 591,510 | +591,510 | $0 | $15.58M | 2.49% | +$15.58M |
| Definium Therapeutics, Inc.(DFTX) | 0 | 385,000 | +385,000 | $0 | $14.65M | 2.34% | +$14.65M |
| COMPASS Pathways plcADS(CMPS) | 0 | 1,056,269 | +1,056,269 | $0 | $13.14M | 2.10% | +$13.14M |
| DBV Technologies S.A.ADS(DBVT) | 909,474 | 1,105,606 | +196,132 | $14.92M | $13.00M | 2.07% | -$1.91M |
| BeOne Medicines AGADS(ONC) | 90,020 | 33,500 | -56,520 | $25.65M | $12.26M | 1.96% | -$13.39M |
| Cogent Biosciences, Inc.(COGT) | 425,000 | 361,927 | -63,073 | $16.45M | $11.59M | 1.85% | -$4.86M |
| Arcus Biosciences, Inc.(RCUS) | 355,800 | 410,000 | +54,200 | $10.97M | $10.59M | 1.69% | -$379.0K |
| BioNTech SEADS(BNTX) | 134,429 | 105,421 | -29,008 | $12.51M | $10.36M | 1.65% | -$2.15M |
| Enliven Therapeutics Inc | 212,500 | 212,500 | 0 | $10.78M | $9.74M | 1.55% | -$1.04M |
| Vaxcyte, Inc.(PCVX) | 0 | 166,000 | +166,000 | $0 | $9.45M | 1.51% | +$9.45M |
| Kymera Therapeutics, Inc.(KYMR) | 47,500 | 84,000 | +36,500 | $5.45M | $9.39M | 1.50% | +$3.94M |
| Allogene Therapeutics Inc | 5,050,000 | 4,550,000 | -500,000 | $10.50M | $7.28M | 1.16% | -$3.22M |
| Zentalis Pharmaceuticals, Inc.(ZNTL) | 0 | 2,007,485 | +2,007,485 | $0 | $5.56M | 0.89% | +$5.56M |
| Inventiva S.A.ADS(IVA) | 1,967,171 | 1,221,225 | -745,946 | $7.44M | $4.51M | 0.72% | -$2.93M |
| Harrow, Inc.(HROW) | 0 | 145,000 | +145,000 | $0 | $4.47M | 0.71% | +$4.47M |
| Arcutis Biotherapeutics, Inc.(ARQT) | 370,000 | 0 | -370,000 | $9.70M | $0 | — | -$9.70M |
| C4 Therapeutics, Inc.(CCCC) | 1,608,815 | 0 | -1,608,815 | $7.51M | $0 | — | -$7.51M |
| Dianthus Therapeutics, Inc.(DNTH) | 108,000 | 0 | -108,000 | $10.53M | $0 | — | -$10.53M |
| EyePoint, Inc.(EYPT) | 720,000 | 0 | -720,000 | $10.30M | $0 | — | -$10.30M |
| Faeth Therapeutics, Inc.(FTH) | 175,050 | 0 | -175,050 | $4.38M | $0 | — | -$4.38M |
| Xenon Pharmaceuticals Inc.(XENE) | 220,000 | 0 | -220,000 | $13.28M | $0 | — | -$13.28M |